Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Trial Highlights: Modulators of Mitochondrial Function.
Capriglia F, Burgess T, Bandmann O, Mortiboys H. Capriglia F, et al. Among authors: bandmann o. J Parkinsons Dis. 2023;13(6):851-864. doi: 10.3233/JPD-239003. J Parkinsons Dis. 2023. PMID: 37694310 Free PMC article. No abstract available.
Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative.
Gonzalez-Robles C, Weil RS, van Wamelen D, Bartlett M, Burnell M, Clarke CS, Hu MT, Huxford B, Jha A, Lambert C, Lawton M, Mills G, Noyce A, Piccini P, Pushparatnam K, Rochester L, Siu C, Williams-Gray CH, Zeissler ML, Zetterberg H, Carroll CB, Foltynie T, Schrag A; EJS ACT-PD Consortium. Gonzalez-Robles C, et al. J Parkinsons Dis. 2023;13(6):1011-1033. doi: 10.3233/JPD-230051. J Parkinsons Dis. 2023. PMID: 37545260 Free PMC article. Clinical Trial.
Polygenic Risk Scores Validated in Patient-Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease.
Arena G, Landoulsi Z, Grossmann D, Payne T, Vitali A, Delcambre S, Baron A, Antony P, Boussaad I, Bobbili DR, Sreelatha AAK, Pavelka L, J Diederich N, Klein C, Seibler P, Glaab E, Foltynie T, Bandmann O, Sharma M, Krüger R, May P, Grünewald A; NCER‐PD and COURAGE‐PD Consortia. Arena G, et al. Among authors: bandmann o. Ann Neurol. 2024 May 20. doi: 10.1002/ana.26949. Online ahead of print. Ann Neurol. 2024. PMID: 38767023
Multimodal assessment of mitochondrial function in Parkinson's disease.
Payne T, Burgess T, Bradley S, Roscoe S, Sassani M, Dunning MJ, Hernandez D, Scholz S, McNeill A, Taylor R, Su L, Wilkinson I, Jenkins T, Mortiboys H, Bandmann O. Payne T, et al. Among authors: bandmann o. Brain. 2024 Jan 4;147(1):267-280. doi: 10.1093/brain/awad364. Brain. 2024. PMID: 38059801 Free PMC article.
The master energy homeostasis regulator PGC-1α exhibits an mRNA nuclear export function.
Mihaylov SR, Castelli LM, Lin YH, Gül A, Soni N, Hastings C, Flynn HR, Păun O, Dickman MJ, Snijders AP, Goldstone R, Bandmann O, Shelkovnikova TA, Mortiboys H, Ultanir SK, Hautbergue GM. Mihaylov SR, et al. Among authors: bandmann o. Nat Commun. 2023 Sep 7;14(1):5496. doi: 10.1038/s41467-023-41304-8. Nat Commun. 2023. PMID: 37679383 Free PMC article.
A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.
Payne T, Appleby M, Buckley E, van Gelder LMA, Mullish BH, Sassani M, Dunning MJ, Hernandez D, Scholz SW, McNeill A, Libri V, Moll S, Marchesi JR, Taylor R, Su L, Mazzà C, Jenkins TM, Foltynie T, Bandmann O. Payne T, et al. Among authors: bandmann o. Mov Disord. 2023 Aug;38(8):1493-1502. doi: 10.1002/mds.29450. Epub 2023 May 29. Mov Disord. 2023. PMID: 37246815 Free article. Clinical Trial.
147 results